v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2024 $ 14,410 $ 4 $ 174,166 $ (159,764) $ 4
Beginning Balance, Shares at Dec. 31, 2024   13,481,917      
Stock-based compensation expense 549   549    
Issuance of common shares from underwritten public offering (net of issuance costs) 8   8    
Issuance of common stock from at-the-market offering (net of issuance costs), Shares   490,073      
Issuance of common stock from at-the-market offering (net of issuance costs) 968   968    
Unrealized loss on investments (5)       (5)
Net loss (5,042)     (5,042)  
Ending Balance at Mar. 31, 2025 10,888 $ 4 175,691 (164,806) (1)
Ending Balance, Shares at Mar. 31, 2025   13,971,990      
Beginning Balance at Dec. 31, 2024 14,410 $ 4 174,166 (159,764) 4
Beginning Balance, Shares at Dec. 31, 2024   13,481,917      
Net loss (10,998)        
Ending Balance at Jun. 30, 2025 6,103 $ 4 176,865 (170,762) (4)
Ending Balance, Shares at Jun. 30, 2025   13,971,990      
Beginning Balance at Mar. 31, 2025 10,888 $ 4 175,691 (164,806) (1)
Beginning Balance, Shares at Mar. 31, 2025   13,971,990      
Stock-based compensation expense 1,174   1,174    
Unrealized loss on investments (3)       (3)
Net loss (5,956)     (5,956)  
Ending Balance at Jun. 30, 2025 6,103 $ 4 176,865 (170,762) (4)
Ending Balance, Shares at Jun. 30, 2025   13,971,990      
Beginning Balance at Dec. 31, 2025 (6,641) $ 4 182,681 (189,326)  
Beginning Balance, Shares at Dec. 31, 2025   15,437,410      
Stock-based compensation expense 561   561    
Issuance of common stock from exercise warrants, Shares   306,506      
Vesting of restricted stock units, Shares   2,500      
Net loss 4,976     4,976  
Ending Balance at Mar. 31, 2026 (1,104) $ 4 183,242 (184,350)  
Ending Balance, Shares at Mar. 31, 2026   15,746,416      
Beginning Balance at Dec. 31, 2025 (6,641) $ 4 182,681 (189,326)  
Beginning Balance, Shares at Dec. 31, 2025   15,437,410      
Issuance of common stock from at-the-market offering (net of issuance costs), Shares   2,080,943      
Issuance of common stock from at-the-market offering (net of issuance costs)   $ 5,800      
Net loss (2,676)        
Ending Balance at Jun. 30, 2026 5,513 $ 6 197,510 (192,002) (1)
Ending Balance, Shares at Jun. 30, 2026   30,736,401      
Beginning Balance at Mar. 31, 2026 (1,104) $ 4 183,242 (184,350)  
Beginning Balance, Shares at Mar. 31, 2026   15,746,416      
Stock-based compensation expense 540   540    
Issuance of common stock from at-the-market offering (net of issuance costs), Shares   49,115      
Issuance of common stock from at-the-market offering (net of issuance costs) 31   31    
Issuance of common shares from private placement (net of issuance costs), Shares   14,938,370      
Issuance of common shares from private placement (net of issuance costs) 10,699 $ 2 10,697    
Issuance of warrants in connection with the private placement 3,000   3,000    
Vesting of restricted stock units, Shares   2,500      
Unrealized loss on investments (1)       (1)
Net loss (7,652)     (7,652)  
Ending Balance at Jun. 30, 2026 $ 5,513 $ 6 $ 197,510 $ (192,002) $ (1)
Ending Balance, Shares at Jun. 30, 2026   30,736,401